Profile
Full Name
ImmunityBio, Inc.Ticker Symbol
IBRXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
July 28, 2015Indexes
Not includedWebsite
http://immunitybio.comEmployees
680Key Details
Price
$2.96
Market Cap
$2.53B(Mid cap)
Last Dividend
-
TTM Dividend Yield
-
Annual Revenue
$14.74M(+2270.58% YoY)
Annual EPS
-$0.62(+46.09% YoY)
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
ImmunityBio doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 31, 25 D. Boral Capital
BuyMar 13, 25 HC Wainwright & Co.
BuyMar 13, 25 D. Boral Capital
BuyMar 6, 25 HC Wainwright & Co.
BuyMar 3, 25 D. Boral Capital
BuyFeb 28, 25 D. Boral Capital
BuyFeb 19, 25 D. Boral Capital
BuyFeb 14, 25 D. Boral Capital
BuyJan 30, 25 D. Boral Capital
BuyJan 27, 25 D. Boral Capital
BuyInstitutional Ownership
- What is the ticker symbol for ImmunityBio?
- Does ImmunityBio pay dividends?
- What sector is ImmunityBio in?
- What industry is ImmunityBio in?
- What country is ImmunityBio based in?
- When did ImmunityBio go public?
- Is ImmunityBio in the S&P 500?
- Is ImmunityBio in the NASDAQ 100?
- Is ImmunityBio in the Dow Jones?
- When was ImmunityBio's last earnings report?
- When does ImmunityBio report earnings?
- Should I buy ImmunityBio stock now?
What is the ticker symbol for ImmunityBio?
The ticker symbol for ImmunityBio is NASDAQ:IBRX
Does ImmunityBio pay dividends?
No, ImmunityBio does not pay dividends
What sector is ImmunityBio in?
ImmunityBio is in the Healthcare sector
What industry is ImmunityBio in?
ImmunityBio is in the Biotechnology industry
What country is ImmunityBio based in?
ImmunityBio is headquartered in United States
When did ImmunityBio go public?
ImmunityBio's initial public offering (IPO) was on July 28, 2015
Is ImmunityBio in the S&P 500?
No, ImmunityBio is not included in the S&P 500 index
Is ImmunityBio in the NASDAQ 100?
No, ImmunityBio is not included in the NASDAQ 100 index
Is ImmunityBio in the Dow Jones?
No, ImmunityBio is not included in the Dow Jones index
When was ImmunityBio's last earnings report?
ImmunityBio's most recent earnings report was on Mar 3, 2025
When does ImmunityBio report earnings?
The next expected earnings date for ImmunityBio is May 9, 2025
Should I buy ImmunityBio stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions